Lipton Karen Shoos Insider Trades

Insider Trading History

Track insider trading activity for Lipton Karen Shoos. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $1.6M 41,833 shares
Last Trade
Jun 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$348k 10,000 shares
$34.80
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $575k 15,000 shares
Last Trade
Jun 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$522k 15,000 shares
$34.80
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $1.22M 31,833 shares
Last Trade
Jun 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$708k 10,000 shares
$70.80
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $575k 15,000 shares
Last Trade
Jun 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 15,000 shares
$70.80
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $836k 21,833 shares
Last Trade
Jun 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.48M 6,500 shares
$381.15
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $395k 10,300 shares
Last Trade
Jun 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.93M 10,300 shares
$381.15
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $76.6k 2,000 shares
Last Trade
Jun 04, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$404k 2,000 shares
$201.75
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $587k 15,333 shares
Last Trade
Jun 04, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$404k 2,000 shares
$201.75
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $1.19M 31,061 shares
Last Trade
Dec 06, 2013 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.88M 17,728 shares
$388.05
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $511k 13,333 shares
Last Trade
Dec 06, 2013 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.88M 17,728 shares
$388.05
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $0 0 shares
Last Trade
Dec 06, 2013 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.88M 17,728 shares
$388.05
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $76.6k 2,000 shares
Last Trade
Jun 19, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$456k 2,000 shares
$228.00
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $511k 13,333 shares
Last Trade
Jun 19, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$456k 2,000 shares
$228.00
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $434k 11,333 shares
Last Trade
Jun 20, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$135k 2,000 shares
$67.50
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $76.6k 2,000 shares
Last Trade
Jun 22, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.2k 2,000 shares
$48.60
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $76.6k 2,000 shares
Last Trade
Sep 22, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 2,000 shares
$59.40
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $115k 3,000 shares
Last Trade
Sep 16, 2010 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$169k 3,000 shares
$56.25
$38.31
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $76.6k 2,000 shares
Last Trade
Dec 23, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$134k 2,000 shares
$67.20
$38.31
Avanti Acquisition
Avanti Acquisition AVAN
Director
Holding Value $120k 12,000 shares
Last Trade
Sep 25, 2008 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$10.04
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $460k 12,000 shares
Last Trade
Sep 25, 2008 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 12,000 shares
$11.65
$38.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up